Relative positioning of B and T cell epitopes drives immunodominance
preprint
OA: closed
CC-BY-ND-4.0
Abstract
Humoral immunity is crucial for protection against invading pathogens. Broadly neutralizing antibodies (bnAbs) provide sterilizing immunity by targeting conserved regions of viral variants and represent the goal of most vaccination approaches. While antibodies can be selected to bind virtually any region of a given antigen, consistent induction of bnAbs in the context of influenza and HIV has been representing a major roadblock. Many possible explanations have been considered, however, none of the arguments proposed so far seems to fully recapitulate the observed counter-selection for broadly protective antibodies. Antibodies can influence antigen presentation by enhancing the processing of CD4 epitopes adjacent to the binding region while suppressing the overlapping ones. We analyzed the relative positioning of dominant B and T cell epitopes in published antigens that elicit strong and poor humoral responses. In strong immunogenic antigens, regions bound by immunodominant antibodies are frequently adjacent to CD4 epitopes, potentially boosting their presentation. Conversely, poorly immunogenic regions targeted by bnAbs in HIV and influenza overlap with clusters of dominant CD4 epitopes, potentially conferring an intrinsic disadvantage for bnAb-bearing B cells in germinal centers. Here we propose the theory of immunodominance relativity, according to which relative positioning of immunodominant B and CD4 epitopes within a given antigen drives immunodominance. Thus, we suggest that relative positioning of B-T epitopes may be one additional mechanism that cooperates with other previously described processes to influence immunodominance. If demonstrated, this theory can improve the current understanding of immunodominance, provide a novel explanation on HIV and influenza escape from humoral responses, and pave the way for new rational design of universal vaccines.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (77)
- Epitope Mapping of the Diphtheria Toxin and Development of an ELISA-Specific Diagnostic Assay via crossref
- doi:10.1080/19420862.2020.1854149 via crossref
- doi:10.1111/imr.12861 via crossref
- doi:10.1016/j.immuni.2015.11.019 via crossref
- doi:10.1016/j.coi.2016.12.004 via crossref
- doi:10.1016/j.cell.2010.10.036 via crossref
- doi:10.1016/j.coi.2006.02.005 via crossref
- doi:10.1016/j.coviro.2017.12.002 via crossref
- doi:10.1038/ni.1946 via crossref
- doi:10.1096/fasebj.3.7.2497040 via crossref
- doi:10.1016/j.coi.2010.04.009 via crossref
- doi:10.1038/ni.3680 via crossref
- doi:10.1038/nature07352 via crossref
- doi:10.1073/pnas.97.16.9026 via crossref
- doi:10.1128/jvi.01056-18 via crossref
- doi:10.1016/j.clim.2012.01.015 via crossref
- doi:10.1084/jem.20200206 via crossref
- doi:10.4049/jimmunol.1901051 via crossref
- doi:10.1126/science.aad9195 via crossref
- doi:10.1016/s0198-8859(97)00092-x via crossref
- doi:10.1172/jci11275 via crossref
- doi:10.1084/jem.178.4.1459 via crossref
- doi:10.1038/314537a0 via crossref
- doi:10.1146/annurev.iy.08.040190.004013 via crossref
- doi:10.1371/journal.pbio.1001523 via crossref
- doi:10.1016/j.vaccine.2012.10.042 via crossref
- doi:10.1126/science.aaf1279 via crossref
- doi:10.1093/infdis/jix292 via crossref
- doi:10.1371/journal.pone.0191194 via crossref
- doi:10.1073/pnas.1214913110 via crossref
- doi:10.1128/jvi.79.11.6957-6968.2005 via crossref
- doi:10.1590/s0100-879x2004000500008 via crossref
- doi:10.3390/v1030802 via crossref
- doi:10.1128/jvi.00754-11 via crossref
- doi:10.1099/vir.0.000120 via crossref
- doi:10.3389/fimmu.2016.00391 via crossref
- doi:10.1038/s41573-019-0056-x via crossref
- doi:10.1126/science.abb7269 via crossref
- doi:10.1016/j.celrep.2018.08.009 via crossref
- doi:10.1128/mbio.02343-19 via crossref
- doi:10.1038/nature13764 via crossref
- doi:10.1111/j.1600-065x.1997.tb01005.x via crossref
- doi:10.1086/314862 via crossref
- doi:10.1016/0140-6736(90)90995-h via crossref
- doi:10.1371/journal.ppat.1005369 via crossref
- doi:10.1038/nri3818 via crossref
- doi:10.4049/jimmunol.140.2.404 via crossref
- doi:10.1016/0006-291x(70)90940-x via crossref
- doi:10.1126/science.2422757 via crossref
- doi:10.1083/jcb.109.1.85 via crossref
- doi:10.1007/bf02918417 via crossref
- doi:10.1002/eji.1830150408 via crossref
- doi:10.4049/jimmunol.140.9.2893 via crossref
- doi:10.4049/jimmunol.138.12.4133 via crossref
- doi:10.1016/s0264-410x(88)80006-9 via crossref
- doi:10.1084/jem.181.6.1957 via crossref
- doi:10.1099/0022-1317-80-7-1609 via crossref
- doi:10.1128/jvi.02033-12 via crossref
- doi:10.1086/315324 via crossref
- doi:10.1021/acs.biochem.8b01123 via crossref
- doi:10.1016/0042-6822(89)90430-3 via crossref
- doi:10.1128/jvi.68.3.1573-1580.1994 via crossref
- doi:10.1038/s41579-020-00459-7 via crossref
- doi:10.1126/science.abj3321 via crossref
- doi:10.1038/s41586-020-2349-y via crossref
- doi:10.1038/s41467-020-16638-2 via crossref
- doi:10.1038/s41590-020-0782-6 via crossref
- doi:10.1038/s41467-021-24435-8 via crossref
- doi:10.1016/j.celrep.2021.109433 via crossref
- doi:10.1074/jbc.m106018200 via crossref
- doi:10.1006/jtbi.1999.1056 via crossref
- doi:10.4049/jimmunol.142.4.1166 via crossref
- doi:10.1128/jvi.75.22.10950-10957.2001 via crossref
- doi:10.1002/eji.200425859 via crossref
- doi:10.1084/jem.20201254 via crossref
- doi:10.1146/annurev-immunol-032712-095916 via crossref
- doi:10.1128/jvi.02026-07 via crossref
Source provenance
- crossref
- last seen: 2026-06-22T06:34:37.213135+00:00
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-05-22T02:00:06.705733+00:00
License: CC-BY-ND-4.0